Credit Suisse’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $571K | Hold |
28,924
| – | – | ﹤0.01% | 2573 |
|
|
2023
Q4 | $507K | Buy |
28,924
+3,516
| +14% | +$61.7K | ﹤0.01% | 2712 |
|
|
2023
Q3 | $441K | Sell |
25,408
-5,847
| -19% | -$102K | ﹤0.01% | 2728 |
|
|
2023
Q2 | $440K | Buy |
31,255
+6,436
| +26% | +$90.6K | ﹤0.01% | 2830 |
|
|
2023
Q1 | $267K | Buy |
24,819
+2,556
| +11% | +$27.5K | ﹤0.01% | 3018 |
|
|
2022
Q4 | $334K | Sell |
22,263
-2,946
| -12% | -$44.1K | ﹤0.01% | 2972 |
|
|
2022
Q3 | $324K | Buy |
25,209
+7,654
| +44% | +$98.4K | ﹤0.01% | 3024 |
|
|
2022
Q2 | $170K | Sell |
17,555
-1,990
| -10% | -$19.3K | ﹤0.01% | 3366 |
|
|
2022
Q1 | $194K | Buy |
19,545
+246
| +1% | +$2.44K | ﹤0.01% | 3365 |
|
|
2021
Q4 | $226K | Buy |
19,299
+3,542
| +22% | +$41.5K | ﹤0.01% | 3403 |
|
|
2021
Q3 | $178K | Buy |
15,757
+752
| +5% | +$8.5K | ﹤0.01% | 3402 |
|
|
2021
Q2 | $209K | Sell |
15,005
-2,418
| -14% | -$33.7K | ﹤0.01% | 3421 |
|
|
2021
Q1 | $322K | Sell |
17,423
-34,736
| -67% | -$642K | ﹤0.01% | 3137 |
|
|
2020
Q4 | $921K | Buy |
52,159
+40,593
| +351% | +$717K | ﹤0.01% | 2621 |
|
|
2020
Q3 | $177K | Sell |
11,566
-15,205
| -57% | -$233K | ﹤0.01% | 3112 |
|
|
2020
Q2 | $682K | Buy |
26,771
+10,052
| +60% | +$256K | ﹤0.01% | 2524 |
|
|
2020
Q1 | $259K | Sell |
16,719
-1,752
| -9% | -$27.1K | ﹤0.01% | 2907 |
|
|
2019
Q4 | $204K | Buy |
18,471
+460
| +3% | +$5.08K | ﹤0.01% | 3309 |
|
|
2019
Q3 | $153K | Buy |
+18,011
| New | +$153K | ﹤0.01% | 3246 |
|